- Home
- SERA
as of 03-16-2026 2:53pm EST
$2.10
$0.03
-1.41%
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SALT LAKE CITY |
| Market Cap: | 77.2M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 69.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.51 | EPS Growth: | 14.66 |
| 52 Week Low/High: | $1.37 - $4.20 | Next Earning Date: | N/A |
| Revenue: | $77,000 | Revenue Growth: | -74.84% |
| Revenue Growth (this year): | 25.84% | Revenue Growth (next year): | 715.79% |
| P/E Ratio: | -4.18 | Index: | N/A |
| Free Cash Flow: | -14245000.0 | FCF Growth: | N/A |
AI-Powered SERA Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 73.46%
73.46%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Sera Prognostics Inc. (SERA)
Boniface John J.
Sell
Chief Scientific Officer
SERA Mar 11, 2026
Avg Cost/Share
$2.04
Shares
1,517
Total Value
$3,094.68
Owned After
145,842
SEC Form 4
Lindgardt Zhenya
Sell
Chief Executive Officer
SERA Mar 11, 2026
Avg Cost/Share
$2.04
Shares
2,973
Total Value
$6,064.92
Owned After
738,314
SEC Form 4
Kearney Paul
Sell
Chief Data Officer
SERA Mar 11, 2026
Avg Cost/Share
$2.04
Shares
1,396
Total Value
$2,847.84
Owned After
163,961
SEC Form 4
Jackson Benjamin
Sell
General Counsel
SERA Mar 11, 2026
Avg Cost/Share
$2.04
Shares
1,027
Total Value
$2,095.08
Owned After
114,720
SEC Form 4
Aerts Austin
Sell
Chief Financial Officer
SERA Mar 11, 2026
Avg Cost/Share
$2.04
Shares
1,019
Total Value
$2,078.76
Owned After
264,452
SEC Form 4
Harrison Robert Gardner
Sell
Chief Information Officer
SERA Mar 11, 2026
Avg Cost/Share
$2.04
Shares
716
Total Value
$1,460.64
Owned After
76,712
SEC Form 4
Lindgardt Zhenya
Sell
Chief Executive Officer
SERA Mar 10, 2026
Avg Cost/Share
$1.90
Shares
22,639
Total Value
$43,014.10
Owned After
738,314
SEC Form 4
Aerts Austin
Sell
Chief Financial Officer
SERA Mar 10, 2026
Avg Cost/Share
$1.90
Shares
6,069
Total Value
$11,531.10
Owned After
264,452
SEC Form 4
Boniface John J.
Sell
Chief Scientific Officer
SERA Mar 9, 2026
Avg Cost/Share
$1.96
Shares
3,038
Total Value
$5,954.48
Owned After
145,842
SEC Form 4
Kearney Paul
Sell
Chief Data Officer
SERA Mar 9, 2026
Avg Cost/Share
$1.96
Shares
2,026
Total Value
$3,970.96
Owned After
163,961
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Boniface John J. | SERA | Chief Scientific Officer | Mar 11, 2026 | Sell | $2.04 | 1,517 | $3,094.68 | 145,842 | |
| Lindgardt Zhenya | SERA | Chief Executive Officer | Mar 11, 2026 | Sell | $2.04 | 2,973 | $6,064.92 | 738,314 | |
| Kearney Paul | SERA | Chief Data Officer | Mar 11, 2026 | Sell | $2.04 | 1,396 | $2,847.84 | 163,961 | |
| Jackson Benjamin | SERA | General Counsel | Mar 11, 2026 | Sell | $2.04 | 1,027 | $2,095.08 | 114,720 | |
| Aerts Austin | SERA | Chief Financial Officer | Mar 11, 2026 | Sell | $2.04 | 1,019 | $2,078.76 | 264,452 | |
| Harrison Robert Gardner | SERA | Chief Information Officer | Mar 11, 2026 | Sell | $2.04 | 716 | $1,460.64 | 76,712 | |
| Lindgardt Zhenya | SERA | Chief Executive Officer | Mar 10, 2026 | Sell | $1.90 | 22,639 | $43,014.10 | 738,314 | |
| Aerts Austin | SERA | Chief Financial Officer | Mar 10, 2026 | Sell | $1.90 | 6,069 | $11,531.10 | 264,452 | |
| Boniface John J. | SERA | Chief Scientific Officer | Mar 9, 2026 | Sell | $1.96 | 3,038 | $5,954.48 | 145,842 | |
| Kearney Paul | SERA | Chief Data Officer | Mar 9, 2026 | Sell | $1.96 | 2,026 | $3,970.96 | 163,961 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q3 Q3 2025 Earnings
8-K BUY Nov 13, 2025 · 100% conf.
2025
Q3
Q3 2025 Earnings
8-K BUYNov 13, 2025 · 100% conf.
AI Prediction BUY
1D
+9.08%
$3.22
Act: +0.34%
5D
+7.08%
$3.16
Act: +6.10%
20D
+1.82%
$3.00
Act: +18.98%
Price: $2.95 Prob +5D: 100% AUC: 1.000
0001193125-25-280167
8-K
false000153496900015349692025-11-132025-11-13
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 13, 2025
Sera Prognostics, Inc. (Exact name of Registrant as Specified in Its Charter)
Delaware
001-40606
26-1911522
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
2749 East Parleys Way Suite 200
Salt Lake City, Utah
84109
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: (801) 990-0520
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.0001 par value per share
SERA
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On November 13, 2025, Sera Prognostics, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2025 and providing business highlights. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any registration statement or other document pursuant to the Securities Act of 1933, as amended, or into any filing or other document pursuant to the Exchange Act, except to the extent required by applicable law or regulation or as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits
Exhibit Number
Description
99.1
Press release dated November 13, 2025.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SERA PROGNOSTICS, INC.
Date:
November 13, 2025
By:
/s/ Austin Aerts
Austin Aerts Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Aug 6, 2025
2025
Q2
Q2 2025 Earnings
8-KAug 6, 2025
0000950170-25-103994
8-K
0001534969false00015349692025-08-062025-08-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 06, 2025
Sera Prognostics, Inc. (Exact name of Registrant as Specified in Its Charter)
Delaware
001-40606
26-1911522
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
2749 East Parleys Way Suite 200
Salt Lake City, Utah
84109
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: (801) 990-0520
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.0001 par value per share
SERA
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On August 6, 2025, Sera Prognostics, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2025 and providing business highlights. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any registration statement or other document pursuant to the Securities Act of 1933, as amended, or into any filing or other document pursuant to the Exchange Act, except to the extent required by applicable law or regulation or as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits
Exhibit Number
Description
99.1
Press release dated August 6, 2025.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SERA PROGNOSTICS, INC.
Date:
August 6, 2025
By:
/s/ Austin Aerts
Austin Aerts Chief Financial Officer
2025 Q1 Q1 2025 Earnings
8-K May 7, 2025
2025
Q1
Q1 2025 Earnings
8-KMay 7, 2025
0000950170-25-065654
8-K
false000153496900015349692025-05-072025-05-07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 07, 2025
Sera Prognostics, Inc. (Exact name of Registrant as Specified in Its Charter)
Delaware
001-40606
26-1911522
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
2749 East Parleys Way Suite 200
Salt Lake City, Utah
84109
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: (801) 990-0520
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.0001 par value per share
SERA
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On May 7, 2025, Sera Prognostics, Inc. issued a press release announcing its financial results for the first quarter ended March 31, 2025 and providing business highlights. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any registration statement or other document pursuant to the Securities Act of 1933, as amended, or into any filing or other document pursuant to the Exchange Act, except to the extent required by applicable law or regulation or as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits
Exhibit Number
Description
99.1
Press release dated May 7, 2025.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SERA PROGNOSTICS, INC.
Date:
May 7, 2025
By:
/s/ Austin Aerts
Austin Aerts Chief Financial Officer
Latest Sera Prognostics Inc. News
SERA Breaking Stock News: Dive into SERA Ticker-Specific Updates for Smart Investing
Compare SERA vs Leading Stocks
See how SERA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SERA Sera Prognostics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.